Certara Logo White Background.png
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
October 25, 2021 16:30 ET | Certara
PRINCETON, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that its Simcyp COVID-19 Vaccine Model has won an R&D 100...
Certara Logo White Background.png
Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021
October 19, 2021 08:00 ET | Certara
PRINCETON, N.J., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of...
Certara Logo White Background.png
Certara Appoints Drayton T. Virkler as Chief Commercial Officer
October 05, 2021 08:00 ET | Certara
PRINCETON, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Drayton T. Virkler to the newly created position...
Certara Logo White Background.png
Certara Completes Acquisition of Pinnacle 21
October 04, 2021 08:00 ET | Certara
PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the completion of the previously announced transaction to acquire...
Certara Logo White Background.png
Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process
September 30, 2021 16:30 ET | Certara
PRINCETON, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the launch of Synchrogenix™ Writer, a new regulatory SaaS product that expedites the...
Certara Logo White Background.png
Certara Announces New Clinical Science Group and Adds Senior Scientific Experts
September 22, 2021 08:00 ET | Certara
PRINCETON, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that it is expanding its Integrated Drug Development (IDD) division with a new clinical...
Certara Logo White Background.png
Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation
September 20, 2021 08:00 ET | Certara
PRINCETON, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the Company has been awarded a grant from the U.S. Food and Drug...
Certara-CMYK-01.jpg
Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
September 13, 2021 16:30 ET | Certara
PRINCETON, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it closed its public offering of 23,000,000 shares of common...
Certara-CMYK-01.jpg
Certara Announces Pricing of Public Offering of Common Stock
September 08, 2021 21:01 ET | Certara
PRINCETON, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of shares of its...
Certara-CMYK-01.jpg
Certara Announces Proposed Public Offering of Common Stock
September 03, 2021 06:10 ET | Certara
PRINCETON, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of...